-
ICPerMed Brief ‘Optimizing Clinical Research for Personalised Medicine: Recommendations for Funders, Regulators and Policy Makers’
22 May 2023 – ICPerMed published a set of recommendations for optimizing personalised medicine (PM) related clinical research as a brief specifically addressed to policy, funding bodies and regulatory agencies. These recommendations have been elaborated by the ICPerMed Working Group „Clinical Studies in Personalised Medicine“ together with the CSA PERsonalised Medicine Trials project, PERMIT. PM-related…
-
Publication of the Strategic Research and Innovation Agenda for Personalised Medicine
28 April 2023 – ICPerMed is happy to announce the publication of the Strategic Research and Innovation Agenda (SRIA) for Personalised Medicine (PM). This SRIA will support a wide range of stakeholders and experts to further develop programs, activities, and research towards PM and care, as well as prevention. In line with this mission, its…
-
Open Access in Personalised Medicine
24 March 2023 – Open Science and Open Access are key aspects of the Responsible Research and Innovation (RRI) approach. It provides online, free, re-usable and shared access to scientific information (peer-reviewed scientific research articles and research data). In order to implement open access policies and data integration of research data into European databases, ICPerMed…
-
Report on SRIA consultation for EP PerMed
13 March 2023 – Publication of the report on the open consultation for the Strategic Research and Innovation Agenda (SRIA) in support for the European Partnership for Personalised Medicine, EP PerMed.
-
EU-Africa PerMed Webinar: Health Technology Assessment under Personalised Medicine
09 March 2023 – Health Technology Assessment (HTA) on personalised medicine focuses on assessing the effectiveness, safety, and cost-effectiveness of diagnostic tools and treatments tailored to individual patients based on their genetic, environmental, and lifestyle factors. HTA can provide important information to support decision-making in the adoption, funding, and use of these technologies in clinical…
-
ERA PerMed’s Final Symposium of the JTC2018
02 March 2023 – ERA PerMed’s final symposium of the Joint Transnational Call 2018 took place from February 28 to March 1 in Cluj-Napoca, Romania and was attended by around 70 on-site and 30 online participants, including researchers and representatives from the European Commission, funding organisations and scientific experts. The symposium aimed to provide the…
-
EU-Africa PerMed Stakeholder Workshop & Summer School
02 March 2023 – The Europe-Africa Personalised Medicine (EU- Africa PerMed) consortium organised its second stakeholder workshop on 20-21 February 2023 and the 1st EU-Africa PerMed Summer School on 22-23 February in Cape Town, South Africa.
-
EP PerMed as an opportunity for interregional cooperation
24 February 2023 – Interreg Europe highlights the relevance of the upcoming European Partnership for Personalised Medicine (EP PerMed) for European regions.
-
Pre-Announcement: ICPerMed Best Practice Recognition 2023
15 February 2023 – ICPerMed is going to launch its sixth recognition. The 2023 Recognition aims to honour, encourage, promote and disseminate the examples of implementation through research in personalised medicine. First authors (applicants from any countries) of candidate proposals published and/or developed between January 1st, 2021 and December 31st, 2022 are eligible to apply.
-
PROPHET: a Personalised Prevention Roadmap for future Healthcare
9 February 2023 – The recently started, EU-funded project PROPHET (a personalised prevention roadmap for future healthcare) aims at supporting the definition and implementation of innovative, sustainable and high-quality personalised strategies that effectively treat chronic diseases.
